• Skip to primary navigation
  • Skip to main content

Highlights:

Read more
  • Careers
  • Support
  • Contact Us
AMRA Medical

AMRA Medical

Insights Within

  • Focus Areas
  • Our Services

      Research Services

      Unlock breakthroughs and power your clinical trials by implementing our research biomarkers to maximize your trial’s success and de-risk the drug development lifecycle. Read more

      Imaging Biomarkers
      MRI-based fat and muscle analysis measures for drug development teams.
      Insights Biomarkers
      Advanced analysis—descriptive, functionally-relevant fat and muscle assessment methodologies.

      Clinical Services

      Our clinical biomarkers provide your practice with easy-to-understand insights that are personalized and informative for each and every patient. Read more

      AMRA® BCP Scan
      Understand your patient’s fat and muscle composition using MRI-based measurements within health and wellness.
      AMRA® MAsS Scan
      Learn more about your patient’s muscle quality using our Muscle Assessment Score

      Services Based on Knowledge

      Read publications, insights articles and view insightful webinars.

      Insights Article

      Revealing the true impact of drug therapies for metabolic diseases through weight-invariant fat distribution assessment using AMRA’s Z-Scores

      Publication

      Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care

      Explore more at our Knowledge Hub →

  • Science

      Science

      AMRA is on the forefront of precision medicine—providing body composition and medical insights driven by our digital health platform, team of experts, and ability to develop MRI biomarkers suitable for both clinical practice and research.

      Read more →

      What We Do
      We analyze MRI to classify and quantify muscle and fat with unprecedented accuracy and precision.
      How We Do It
      Our process of imaging technology and a massive reference database for fat and muscle composition.
      Why It Matters
      Our data guide decision-making—impacting your clinical trials and patient’s lives.
      Technology
      We’ve developed a patented, automated method for classifying and quantifying fat and muscle groups.
  • Knowledge Hub
  • About

      Company

      Our Story
      Read the story of AMRA—how it all started in academic research and grew into a science-driven partner helping researchers see what truly matters.
      Our Team
      At AMRA Medical, our work is powered by passionate people committed to advancing science and clinical outcomes. If you’re driven by curiosity, innovation, and impact, we’d love to meet you.
      Investors
      Our investors share our vision for advancing healthcare through deeper insights into the human body. Their expertise and perspective help us accelerate innovation, expand our global reach and turn that shared ambition into lasting impact.
      News
      Browse the latest updates from AMRA, including company news and press releases, recent research highlights, and stories showcasing ground-breaking health informatics innovation.
      Events
      Explore our event schedule below to see where we’re engaging with researchers, clinicians, industry partners, and other key stakeholders in order to drive progress.
      Media Kit
      AMRA’s Media Kit provides access to essential materials about AMRA, including relevant company information and useful brand assets.

      About AMRA

      AMRA Medical is a global leader in health informatics, pioneering fat and muscle analysis with proprietary MRI-based technologies. Our gold-standard platform delivers precise biomarkers, offering a deeper understanding of metabolic and musculoskeletal health. AMRA supports data-driven decision-making in research and clinical care through standardized, cloud-based workflows—enabling actionable insights from early discovery to clinical outcomes.

      Read more →

  • Get Started

Beyond Weight Loss

Quantitative MRI Insights from the STEP UP Trial

November 11, 2026

As obesity therapies advance, understanding what changes during weight loss—not just how much weight is lost—is increasingly important for clinical development.

Traditional measures, including body weight and DXA-derived lean mass, provide meaningful information but cannot distinguish changes in skeletal muscle volume, muscle composition, and adipose tissue distribution. A recently published secondary analysis of Novo Nordisk’s Phase 3b STEP UP trial demonstrates how quantitative MRI can provide more detailed insights into these treatment-related changes.

STEP UP

Looking beyond body weight

The analysis evaluated body composition and physical function in adults with obesity receiving once-weekly semaglutide (7.2 mg or 2.4 mg) or placebo, alongside lifestyle intervention, over 72 weeks.

Using AMRA® Researcher, investigators assessed adipose tissue distribution, thigh skeletal muscle volume, and muscle fat infiltration. Physical function was evaluated using the 30-second sit-to-stand test.

Key findings

In the pooled semaglutide groups:

  • Weight reduction: Mean body weight decreased by 17.4% (19.5 kg)
  • Adipose tissue: A significant portion of the total mass loss consisted of fat mass, including a 1.5 L reduction in visceral adipose tissue.
  • Muscle volume: Thigh skeletal muscle volume decreased by 1.1 L, corresponding to a 0.35 reduction in weight-invariant muscle volume z-score.
  • Muscle composition: Muscle fat infiltration declined by 0.92 percentage points, approximately a 10% relative reduction.
  • Physical function: Performance on the 30-second sit-to-stand test was maintained.

In summary, the study showed that participants treated with semaglutide as an adjunct to lifestyle intervention lost substantial body and visceral adipose tissue volumes, and showed reductions in both thigh skeletal muscle volume and thigh muscle fat infiltration with preserved physical function as indicated by the sit-to-stand test.

Implications for obesity drug development

The STEP UP findings underscore the value of assessing muscle quantity and composition as distinct endpoints rather than relying on body weight or lean mass alone.

Quantitative MRI enables more detailed characterization of treatment-related changes in adipose tissue distribution, skeletal muscle volume, and muscle fat infiltration.

These measurements obtained via MRI can help sponsors:

  • Characterize the effect of weight loss therapies on body composition beyond total weight change.
  • Evaluate muscle-related outcomes using distinct measures of muscle volume and muscle composition.
  • Generate evidence to support comparisons across therapeutic approaches and inform future clinical development.

As the obesity treatment landscape evolves, integrating advanced body composition measurements into clinical trials can provide a more comprehensive understanding of treatment effects and potentially support therapeutic differentiation.

Download this article as PDF

Want to know more?

View the full publication

Discover how AMRA can support advanced body composition assessment in your clinical development program.

Contact Us
Knowledge Hub
  • Twitter
  • Facebook
  • LinkedIn

Get all the latest updates from AMRA

Valuable insights and exclusive updates from AMRA Medical on the MRI-based fat and muscle analytics shaping research and clinical care, delivered straight to your inbox.

Footer icon
  • Our Services
    • Research Services
    • Clinical Services
  • About Us
    • Our Team
    • Careers
    • News
    • Media Kit
  • Knowledge Hub
    • Insights Articles
    • Webinar
    • Publications
© 2026 AMRA Medical AB
  • Data Privacy Policy
  • Cookie Policy
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}